Article
The panel members discuss the question of how much would it cost to abolish the SGR.
Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer
Frameworks for Advancing Health Equity: Community Wellness Centers
Cost Effectiveness Varies in TAS-102 Plus Bevacizumab Third Line Treatment
Exploring Consumer Perspectives on Network Adequacy Definitions
Steady Premium Hikes Continue: Employer Health Costs Rise Another 7% in 2024
Patient Assignment and Quality Performance: A Misaligned System